Slide 1: Fourth Quarter 2024 Earnings
Click Here to Edit Title Fourth Quarter 2024 Earnings February 5, 2025
Slide 2: Cautionary Statement
Cautionary Click Here to Statement Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements ma
Slide 3: IDEX 2024 Highlights
IDEX 2024 to Click Here Highlights Edit Title Strong price capture and operational excellence Stability in daily order rates Solid performance of key initiatives amplifying pockets of growth Record FSDP Sales in the fourth quarter Completed our largest acquisition with Mott…integration ahead of sche
Slide 4: Leveraging Scale to Drive Growth and Earnings
Leveraging Click Here to Scale Edit to Title Drive Growth and Earnings Materials Science Intelligent Severe Duty Fire and Life Sciences Applications Water Flow Safety • Global broadband satellite • Pharma R&D and • Cloud technologies for • Highly engineered pumps & • Mission-critical products for co
Slide 5: Capital Deployment
Capital Click Here Deployment to Edit Title Mott Acquisition in Funnel Update Strong Balance Sheet Review • Closed transaction on • Focused M&A approach and • Able to increase leverage for September 5, 2024 criteria guide acquisition the right transaction • Integration remains ahead of process • Com
Slide 6: Q4 and FY 2024 Financial Performance
Q4 Click & Here FY 2024 to Edit Financial Title Performance ($ in millions excl. EPS) Sales Adj. EBITDA Margin* Adj. EPS* Free Cash Flow* +3% Q4 / -2% FY Organic* +60 bps Q4 / -80 bps FY +11% Q4 / -4% FY -12% Q4 / -4% FY $863 $2.04 26.4% $179 $789 $1.83 25.8% $157 Q4'23 Q4'24 Q4'23 Q4'24 Q4'23 Q4'24
Slide 7: Q4 2024 Adjusted EBITDA Walk
Q4 Click 2024 Here Adjusted to Edit Title EBITDA Walk ($ in millions) 4Q’23 ACT Volume Flow Price / Mix Resource Acq / Div / FX 4Q’24 ACT Adj. EBITDA Thru Productivity / Investment / Adj. EBITDA Inflation Discretionary Flow thru @ Organic flow Total flow PY GM%* thru** through 42.7% 53% 32% **Exclud
Slide 8: 2025 Full Year Guidance Bridge
2025 Click Here Full Year to Edit Guidance Title Bridge ($ in millions excl. EPS) Sales ($M) EPS FY 2024 - Reported $3,269 $6.64 Fair value inventory step-up charges 0.11 Restructuring expenses and asset impairments 0.09 Gain on sale of business (0.05) Acquisition-related intangible asset amortizati
Slide 9: 2025 Guidance Summary
2025 Click Here Guidance to Edit Summary Title Full Year First Quarter Current Guidance Current Guidance Organic Revenue % vs Prior Year* 1% - 3% (4%) – (3%) Adjusted EBITDA %* 27.5% – 28.0% 24.1% - 24.5% Reported Earnings Per Share $6.56 - $6.96 $1.18 - $1.24 Adjusted Earnings Per Share* $8.10 - $8
Slide 10: 2025 Pacing Considerations
2025 Click Here Pacing to Considerations Edit Title • Sales performance will not be linear across 2025 due to anticipated second- Revenue Growth half recovery of Semiconductor markets, timing of Water project deliveries, and expected pacing of Mott projects • Expect modest recovery through the year
Slide 11: IDEX Value Drivers
IDEXHere Click ValuetoDrivers Edit Title ORGANIC INORGANIC MARGIN GROWTH GROWTH EXPANSION • Leading market entitlement • Strong funnel of M&A opportunities • Leading the IDEX Op Model • Pricing Execution • Fast growing companies • 80/20 • Growth Bets Prioritization • Disciplined capital deployment •
Slide 12: Appendix
Click Here to Edit Title APPENDIX
Slide 13: Q4 and FY 2024: Health & Science Technologies
Q4 Click & Here FY 2024: to Edit Health Title & Science Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Q4 Highlights +8% Q4 / +7% FY Organic* Flat Q4 / -7% FY Organic* +60 bps / FY -60 bps • Life Sciences & Analytical Instrumentation $373 contract on tough comparable; markets $353 $31
Slide 14: Q4 and FY 2024: Fluid & Metering Technologies
Q4 Click & Here FY 2024: to Edit Fluid Title & Metering Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Q4 Highlights +2% Q4 / -2% FY Organic* +3% Q4 / Flat FY Organic* +80 bps / FY -50 bps • Strong Municipal Water performance due to positive market fundamentals and $299 $299 31.6% $28
Slide 15: Q4 and FY 2024: Fire & Safety / Diversified Products
Q4 Click & Here FY 2024: to Edit FireTitle & Safety / Diversified Products ($ in millions) Orders Sales Adj. EBITDA Margin* Q4 Highlights +5% Q4 / +7% FY Organic* +8% Q4 / +4% FY Organic* -80 bps / -20 bps • Strong Fire and Safety performance driven by Integrated Systems share gain and $193 $184 $17
Slide 16: Full Year 2024 Adjusted EBITDA Walk
Full ClickYear Here2024 to Edit Adjusted Title EBITDA Walk ($ in millions) FY’23 ACT Volume Flow Price / Mix Resource Acq / Div / FX FY’24 ACT Adj. EBITDA Thru Productivity / Investment / Adj. EBITDA Inflation Discretionary Flow thru @ Organic flow Total flow PY GM%* thru** through 44.2% Unfavorable
Slide 17: Non-GAAP Reconciliations
Click Here to Edit Title Non-GAAP Reconciliations
Slide 18: Reconciliations of Net Sales to Organic Sales; Adjusted Gross Profit
Table 1: Reconciliations of the Change in Net Sales to Organic Sales FMT HST FSDP IDEX For the Quarter Ended December 31, 2024 Change in net sales —% 19% 8% 9% Less: Net impact from acquisitions/divestitures(1) (2%) 19% —% 6% Impact from foreign currency (1%) —% —% —% Change in organic sales 3% —% 8
Slide 19: Reconciliations of Adjusted Net Income and Diluted EPS
Table 3: Reconciliations of Reported-to-Adjusted Net Income Attributable to IDEX and Diluted EPS Attributable to IDEX (in millions, except per share amounts) For the Quarter Ended For the Year Ended December 31, December 31, 2024 2023 2024 2023 Reported net income attributable to IDEX $ 123.2 $ 108.
Slide 20: Reconciliations of Net Income to Adjusted EBITDA
Table 4: Reconciliations of Net Income to Adjusted EBITDA (dollars in millions) For the Quarter Ended For the Year Ended December 31, December 31, 2024 2023 2024 2023 Reported net income $ 123.2 $ 108.3 $ 504.6 $ 595.6 Provision for income taxes 28.0 31.9 134.7 164.7 Interest expense - net 16.7 11.6
Slide 21: Reconciliation of Estimated 2025 Organic Sales and Diluted EPS
Table 6: Reconciliation of Estimated 2025 Change in Net Sales to Change in Organic Sales Guidance First Quarter 2025 Full Year 2025 Low End High End Low End High End Estimated change in net sales —% 1% 4% 6% Less: Net impact from acquisitions/divestitures(1) 5% 5% 4% 4% Impact from foreign currency
Slide 22: Reconciliation of Estimated 2025 Net Income to Adjusted EBITDA
Table 8: Reconciliation of Estimated 2025 Net Income to Adjusted EBITDA (dollars in millions) Guidance First Quarter 2025 Full Year 2025 Low End High End Low End High End Estimated Reported net income $ 89.8 $ 94.8 $ 499.9 $ 530.0 Provision for income taxes 26.3 27.7 145.8 154.7 Interest expense - n